Evonile Pharma sets rights issue price, ratio and November 11 record date
EVONILE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.6 pts less than Nifty Microcap 250 and in line with its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Evonile Pharma has set terms for a rights issue of 10,287,832 partly paid shares at Rs 860 each, worth Rs 8,847.54 million. The record date is November 11, 2026, and eligible holders may subscribe for 5 shares for every 12 held. The issue runs from November 19 to December 3, 2026. Payment is Rs 645 per share initially and Rs 215 on the final call.
Eligible holders need to pay Rs 860 per right share, with Rs 645 upfront, to preserve ownership; non-participants will be diluted if fully subscribed.